SynBioBeta Speaker
Eric Kelsic
CEO
Dyno Therapeutics
May 2026, SynBioBeta
Speaker
Eric Kelsic is a scientist and entrepreneur leading the transformation of gene therapy through artificial intelligence. As the CEO and Co-founder of Dyno Therapeutics, he is pioneering an AI-powered platform to solve the industry’s greatest bottleneck: the safe and effective in vivo delivery of genetic medicines.Eric’s work is rooted in a "physics-first" philosophy, viewing biological systems as programmable machines. Prior to founding Dyno, he was a researcher in George Church’s lab at the Wyss Institute of Harvard Medical School, where he led the team that developed Dyno’s core technology. During this time, he published foundational research in Science, measuring the first comprehensive fitness landscape of the AAV capsid and co-discovering the AAV MAAP gene.Under his leadership, Dyno has raised over $100M in financing (including a Series A led by a16z) and established a dominant partnership network with global leaders like Astellas, Roche, and NVIDIA. Eric holds a PhD in Systems Biology from Harvard University and a BS in Physics from Caltech. He has been recognized as one of Endpoint News’ "20 under 40" next-gen biotech leaders and Xconomy’s Startup Founder of the Year.
All Categories
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Conference Pass
1,995
USD
Save $1,000
Regular Rate
$2,995
Access to all 120+ Sessions
Attendee Directory
Networking Reception
1:1 Partnering App
1:1 Meeting Space
Meals & Refreshments
Post Event Video Access
Price increases in
04:13:05:07
Purchase Pass
Purchase Pass
Cyber Week Deal
Buy 1 Conference Pass, Get 1 Expo Pass Free
Previous Speakers Include
Join for the latest
SynBioBeta event updates.